Brexit’s Messy Side: Cancer Trials Hit Hard

Brexit isn’t just about politics—it’s slowing down cancer research in the UK! Since leaving the EU, researchers are dealing with delayed clinical trials, drug import headaches, and even destroyed samples. Cancer Research UK says 80% of scientists are struggling to collaborate with EU partners, and costs are up across the board. Their fix? Less red tape, smoother trade, and better data sharing with Europe. It’s wild how much this impacts real lives and breakthroughs! #BrexitImpact #CancerResearch #ScienceMatters #ClinicalTrials #UKNews #Health